Anebulo Pharmaceuticals (ANEB) Earnings Date & Reports
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ANEB is expected to report earnings to rise 160.00% to -12 cents per share on February 06
Q4'25
Est.
$-0.13
Q3'25
Beat
by $0.07
Q2'25
Est.
$-0.05
Q1'25
Beat
by $0.04
Q4'24
Missed
by $0.01
The last earnings report on November 13 showed earnings per share of -5 cents, beating the estimate of -11 cents. With 5.72K shares outstanding, the current market capitalization sits at 94.91M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ANEB showed earnings on November 13, 2025. You can read more about the earnings report here.